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Abstract:  The  availability  of  continuous  glucose  monitoring  (CGM)  sensors  allows 
development of new strategies for the treatment of diabetes. In particular, from an on-line 
perspective, CGM sensors can become ―smart‖ by providing them with algorithms able to 
generate  alerts  when  glucose  concentration  is  predicted  to  exceed  the  normal  range 
thresholds. To do so, at least four important aspects have to be considered and dealt with 
on-line. First, the CGM data must be accurately calibrated. Then, CGM data need to be 
filtered in order to enhance their signal-to-noise ratio (SNR). Thirdly, predictions of future 
glucose concentration should be generated with suitable modeling methodologies. Finally, 
generation of alerts should be done by minimizing the risk of detecting false and missing 
true  events.  For  these  four  challenges,  several  techniques,  with  various  degrees  of 
sophistication,  have  been  proposed  in  the  literature  and  are  critically  reviewed  in  this 
paper. 
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1. Introduction  
The knowledge of glucose concentration in blood is a key aspect in the quantitative understanding 
of  the  glucose-insulin  system  and  in  the  diagnosis  and  treatment  of  diabetes.  The  use  of  signal 
processing techniques on glucose data started some decades ago, when glucose time-series in a given 
individual could be obtained in laboratories from samples drawn in the blood at a sufficiently high 
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rate. In particular, an important body of literature of the 80s and 90s employed not only linear (e.g., 
correlation  and  spectrum  analysis,  peak  detection),  but  also  nonlinear  (e.g.,  approximate  entropy) 
methods  to  investigate  oscillations  present  in  glucose  (and  insulin)  time-series  obtained,  during 
hospital monitoring, by drawing blood samples every 10–15 min for up to 48 h [1-3]. At that time, 
long term (e.g., days or months) studies resorted to self-monitoring blood glucose (SMBG) data, i.e.,  
three-to-four samples per day obtained by the patient himself by using fingerstick glucose meters. The 
retrospective analysis of SMBG time-series was used by physicians, together with the information 
taken  from  the  ―patient’s  diary‖  (e.g.,  insulin  dosage,  meals  intake,  physical  exercise)  and  some 
glycaemic  indexes  (typically  HbA1c),  to  assess  glucose  control  and  the  effectiveness  of  a  
particular therapy [4-7].  
New scenarios in diabetes treatment were presented in the last ten years, when minimally invasive 
continuous glucose monitoring (CGM) sensors, able to monitor glucose concentration continuously for 
several days, entered clinical research [8-15]. This calls for more advanced techniques for studying 
glucose time-series. For instance, new insights can be obtained by analyzing the dynamics of the 
glucose signal, see e.g., Rahaghi and Gough [16] for a review. From a more practical point of view, 
retrospective analysis of CGM in place of SMBG data can facilitate diabetes management in a given 
individual (see Clarke and Kovatchev [17] for a review of the available statistical tools). In addition, 
since  CGM  devices  can  provide  glucose  readings  in  real-time,  new  on-line  applications,  with  a 
potentially great impact in the patient’s daily life, have become of great interest. For instance, CGM 
signals are a key component of the so-called artificial pancreas, a device conceived for Type 1 diabetic 
patients  aimed  at  maintaining  glucose  concentration  within  safe  ranges  by  infusing  insulin 
subcutaneously  via  a  pump  under  the  control  of  a  closed-loop  algorithm  (see  Hovorka  and  
Cobelli et al. for two recent reviews [18,19]). Another important on-line application of CGM sensors is 
the  generation  of  alerts  when  glucose  concentration  is  predicted  to  exceed  the  normal  range  
thresholds [20]. These applications require that CGM sensors become ―smart‖ by means of algorithms 
able to interpret glucose levels in real-time. Indeed, several CGM sensors already in the market have 
some kind of alert system on board, even if their performance is still not satisfactory. In order to 
properly  generate  hypo/hyperglycemic  alerts,  in  fact,  at  least  four  important  aspects  have  to  be 
considered. First, CGM data need to be accurately calibrated. Then, CGM data need to be filtered in 
order to enhance their signal-to-noise ratio (SNR). Thirdly, prediction of future glucose concentrations 
should  be  generated  with  suitable  modeling  methodologies.  Finally,  generation  of  alerts  should 
minimize the risk of detecting false/missing true events. For these four challenges, several techniques, 
with various degrees of sophistication, have been proposed in the literature. The main achievements in 
this area are critically reviewed in this paper. Notably, being exhaustiveness difficult to achieve and, in 
any  case,  beyond  the  scope  of  the  present  special  issue,  we  encourage  the  reader  to  also  make 
reference  to  other  reviews,  with  content  in  great  part  complementary  to  ours,  which  have  been 
published very recently [21]. Finally, we note that we will review only general aspects, i.e., signal 
processing, while possible sensor-dependant sources of error, e.g., related to specific sensor physics, 
chemistry and electronics, are not addressed here. Sensors 2010, 10                                       
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2. Calibration  
Most  of  the  commercial  minimally  invasive  CGM  systems,  e.g.,  and  the  CGMS
®  (Medtronic 
Minimed  Inc,  Northridge,  CA,  USA)  [22],  the  GlucoDay
®  (Menarini  Diagnostics,  Florence,  
Italy) [23], the FreeStyle Navigator
® (Abbott Diabetes Care, Alameda, CA, USA) [24] and the Seven
® 
(DexCom Inc, San Diego, CA, USA) [25], exploit the glucose-oxidase principle, which requires that 
the measured current (e.g., in nA) be transformed into glucose levels (e.g., in mg/dL) by using one, or 
more, SMBG samples. This step is commonly referred to as a calibration [26]. Several studies have 
been performed in order to assess the influence of the number, accuracy, and temporal position of the 
reference  SMBG  samples,  as  well  as  by  the  trend  of  glucose  concentration  at  their  pick  up  
times  [27,28].  An  important  point  related  to  calibration  is  that  CGM  sensors  are  placed  in  the 
subcutaneous tissue and thus they measure interstitial glucose (IG) rather than blood glucose (BG) 
concentration. In dynamic conditions, e.g., after a meal, IG and BG can be markedly different because 
of  the  existence  of  a  BG-to-IG  kinetics  which,  in  the  literature,  has  been  described  by  a  
two-compartment model [29], i.e., 
BG(t)
τ
g
IG(t)
τ
1
(t) G I    
 
(1)  
where g represents the static gain of the BG-to-IG system (which we can consider equal to 1, i.e., in 
steady state, the concentration of glucose in the blood and in the interstitium are equal) and ˄ is a time 
constant (which can vary between individuals). Equation (1) acts as a first order, linear, low-pass filter, 
and introduces a distortion, i.e., attenuation in amplitude and phase delay, which is readily observable 
in Figure 1 (top panel). This figure shows a comparison, performed in a clinical study [30], on a type 1 
diabetic  subject,  between  and  a  FreeStyle  Navigator®  CGM  profile  and  BG  references  collected  
every 15 min and measured in laboratory by YSI (Yellow Springs, OH, USA). Note that, in this and all 
the figures throughout the paper, time 0 is when data recording begins. 
The existence of a BG-to-IG kinetics, however, is not able to explain some of the discrepancies 
which are evident along the y-axis, e.g., in the interval between 18–25 h. This difference is likely due 
to a change of behavior of the CGM sensor performance after its initial calibration. 
The  fact  that  CGM  profiles  can  be  affected  by  calibration  problems  can  be  critical  in  several 
applications,  e.g.,  alert  generation  systems  and  artificial  pancreas.  For  this  reason,  real-time 
―recalibration‖ of CGM data is desirable, where, for recalibration, we intend a step where the sensor 
output (in mg/dl) is processed by an algorithm (e.g., external to the device) in order to improve its 
accuracy.  After  recalibration,  the  difference  between  BG  and  CGM  samples  should  be  due  to  
BG-to-IG kinetics only. 
Several studies in the literature tried to cope with the recalibration problem, mostly retrospectively. 
A  detailed  study  has  been  presented  by  the  DirecNet  Study  Group  [31],  which  analyzed  the 
improvement in CGMS sensor accuracy by retrospectively modifying the number and timing of the 
calibration points. Results evidenced the fact that the timing of the calibration points is even more 
important than the number. In particular, performing calibrations during periods of relative glucose 
stability,  i.e.,  where  the  point-to-point  difference  due  to  the  BG-to-IG  kinetics  is  minimized, 
significantly improves the accuracy. Sensors 2010, 10                                       
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Figure 1. Representative type 1 diabetic subject. Top: BG references (stars) vs. original 
FreeStyle Navigator® CGM profile (continuous line). Bottom: BG references (stars) vs. 
CGM profile (blue line) profile recalibrated by the method of King et al. [32].  
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A more recent recalibration procedure, thought for an off-line application, is that presented by  
King et al. [32], which is based on the linear regression model: 
y = ax + b    (2)  
where a and b are recalibration parameters which are determined by fitting them against a couple of 
BG and CGM pairs, i.e., y and x in Equation (2), respectively, collected at the same time. For instance, 
once applied to the data of Figure 1 (top), where frequently collected references are available and used 
to fit Equation (2), this method produces the improved CGM profile shown in Figure 1 (continuous line, 
bottom panel). A more sophisticated recalibration approach was presented by Kuure-Kinsey et al. [33], 
where a dual-rate Kalman filter is used. The latter method exploits sparse SMBG measurements and 
can estimate a correction factor for the sensor gain in real-time.  
None  of  the  above  recalibration  algorithms  consider  explicitly  the  distortion  introduced  by  
BG-to-IG kinetics and the possibly time-varying behavior of sensor performance (the sensor gain is 
estimated  only  once  for  the  entire  monitoring).  A  first  comprehensive  description  of  the  CGM 
measurement process is due to Knobbe and Buckingham [34]: BG-to-IG kinetics model was explicitly Sensors 2010, 10                                       
 
 
6755 
taken into account in order to reconstruct BG levels at continuous time from CGM measurements and 
an Extended Kalman Filter (EKF) approach was used to estimate the unknown variables. In a recent 
work of Facchinetti et al. [35], this idea was further developed in order to deal with recalibration. 
Reference SMBG samples were considered to be available on a sparse grid (e.g., four samples per day) 
and corrupted by additive measurement error, as: 
SMBG(k) = ˆ(k)BG(k) + e(k)    (3)  
where ˆ(k) is a flag which is equal to 1 only at the times k when the SMBG sample is collected (the 
sampling interval is that of the CGM sensor). The measured CGM profile was modelled as:  
CGM(k) = (1 + ʱ(k))IG(k) + v(k)  (4)  
where IG(k) represents the ―true‖, perfectly calibrated, interstitial glucose level, v(k) is the random 
additive measurement error, and ʱ(k) is a random multiplicative value which simulates the (possibly 
time-varying) deviation of the sensor gain from the ideal unit value [36]. IG(k) and BG(k) can be 
easily  related  by  discretizing  the  continuous-time  differential  equation  of  Equation  (1)  (using  a 
―population‖  value  for  ˄).  In  order  to  estimate  IG(k)  and  ʱ(k)  from  the  measured  CGM(k)  and 
SMBG(k) data, an a priori model is postulated in order to express the expected regularity of ʱ(k) and 
BG(k),  i.e.,  their  temporal  profile  is  expected  to  be  ―smooth‖.  In  particular,  ʱ(k)  and  BG(k)  are 
modeled as the multiple integration of a white noise process (see Section 3 for more details on the 
formulation of a priori models of signal smoothness).  
Under these assumptions, a nonlinear state-space nonlinear dynamic model can be obtained, where 
the unknown IG(k) and ʱ(k) represent two of the unknown states, which can be estimated by EKF. An 
example on real data (collected in a type 1 diabetic subject) is shown in Figure 2, where only the two 
BG samples denoted by open bullets (top panel) are used to obtain, starting from the original CGM 
profile (blue line), the recalibrated CGM profile (green line). BG samples denoted by asterisks are not 
used for recalibration and are only left on the plot as a reference in order to graphically demonstrate 
the improvement of accuracy obtained by recalibration. In particular, after recalibration, the RMSE 
calculated between the CGM and the BG time-series decreases from 41 mg/dL to 32 mg/dL (–22%). 
The  method  is  causal  (thus  potentially  usable  on  line)  and  also  provides  the  time  course  of  the 
estimated gain deviation (k) (bottom panel). 
Realistic in silico simulations, obtained by using a simulator of the glucose-insulin system [37], 
showed that the recalibration method of Facchinetti et al. [35] improves the accuracy of CGM signals 
more than both  the methods  of King  et al.  [32] and  Knobbe and  Buckingham [34]. However, in 
Facchinetti  et  al.  [35]  it  is  also  stated  that  the  nonlinearity  of  EKF  can  render  some  steps,  e.g., 
initialization of covariance matrices, critical and can also require rather long ―burn-in‖ intervals. These 
difficulties can be circumvented by simpler recalibration strategies like those of Guerra et al. [38] and 
Facchinetti  et  al.  [39]  which,  by  embedding  a  deconvolution  procedure,  are  able  to  account  for  
BG-to-IG kinetics equally well. Sensors 2010, 10                                       
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Figure 2. Representative type 1 diabetic subject (data taken from Kovatchev et al. [30]). 
Top: measured CGM (blue line), SMBG samples used for recalibration (copper circles), 
recalibrated CGM (green line), and other available SMBG samples plotted as reference 
(asterisks). Bottom: estimated deviation of the sensor gain from the unit value.  
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3. Denoising  
In addition to calibration errors, the CGM signal is also corrupted by a random noise component. 
The  noise  typically  dominates  the  true  signal  at  high  frequency  and  is  usually  considered  to  be 
additive: 
k k k v u y     (5)  
where uk is the actual, but unknown, glucose level at time tk and vk is the random measurement error. 
The amount of noise corrupting the true glucose level is dependent on the sensor technology. For 
instance,  some  CGM  profiles  are  more  ―stable‖  than  others,  as  shown  in  Figure  3,  where  the  
time-series, measured for 24 h in two diabetic volunteers through the FreeStyle Navigator® (top panel) 
and  the  GlucoDay®  (bottom  panel),  are  displayed:  in  terms  of  Equation  (5),  the  variance  of  the 
random process {vk} is lower in the first case (top panel). Moreover, a given sensor technology may 
behave differently in different subjects, e.g., the variance of {vk} may vary among subjects (compare Sensors 2010, 10                                       
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the noise affecting the FreeStyle Navigator® time-series of Figure 3 and Figure 1). Another, less 
appreciated, ingredient of the noise affecting CGM data is that the SNR may even vary during a given 
recording. For instance, in the top panel of Figure 3, the noise variance in the time interval (18,24) is 
larger than in (8,18). 
Figure 3. Two representative type 1 diabetic CGM time series. Top: FreeStyle Navigator® 
time series (1 min sampling), taken from Kovatchev et al. [30]. Bottom: GlucoDay® time 
series (3 min sampling) (taken from Maran et al. [44]). 
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Given the expected spectral characteristics of noise, (causal) low-pass filtering [40] represents the 
most natural candidate to denoise CGM signals. One major problem in low-pass filtering is that, since 
signal and noise spectra normally overlap, it is not possible to remove noise vk from the measured 
signal yk without also distorting the true signal uk. In particular, distortion results in a delay affecting 
the estimate û k with respect to the true uk: the more the filtering, the larger the delay. It is easily 
appreciated that having a consistently delayed, even if less noisy, CGM signal could severely limit its 
use in practice, e.g., for the generation of timely hypo-alerts. A clinically relevant issue is thus the 
establishment of a suitable compromise between the regularity of û k and its delay with respect to the 
true uk. Understanding how denoising is done inside commercial CGM devices is often difficult, but Sensors 2010, 10                                       
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evidence inferred from the patent literature indicate that nonlinear pre-filtering and moving-average 
(MA) filters are very often used [23-25].  
Nonlinear pre-filtering like signal clipping, median filtering, and hard-bounding, are used in order 
to deal with e.g., spurious spikes which may occasionally occur during the monitoring (see e.g., the 
artifacts  in  the  bottom  panel  of  Figure  3,  likely  due  to  perturbations  in  the  functioning  of  the 
microdialysis  fiber  of  the  GlucoDay®  sensor  induced  by  patient  movements).  For  instance,  
hard-bounding considers, at any sampling time, the absolute difference between the present and the 
previous  sample:  if  this  value,  relative  to  the  sampling  period,  is  higher  than  the  maximum 
physiologically allowed, e.g., 4 mg/dL min, the last sample is corrected accordingly.  
As far as MA filtering is concerned, having fixed the so-called order M of the filter, the estimate of 
the signal at the k-th sampling time is a weighted sum of the last M measured samples: 
  1 M k M 1 k 2 k 1 M
1 i
i
k y c ... y c y c
c
1
u ˆ   

   

 
(6)  
where c1, c2,… cM are positive real numbers. The order M and the weights {ck} are crucial parameters 
to be tuned in the filter design. For instance, one choice is to make all the {ck} equal. Another frequent 
choice is to let ci = μ
i , where  is a positive real (between 0 and 1) which, de facto, acts as a forgetting 
factor (the higher , the more slowly past data are forgotten). As far as M is concerned, increasing M 
in general produces a higher low-pass filtering. This can improve noise reduction, but can also result in 
a significant, and possibly unacceptable, signal distortion, e.g., the filtered sequence û k cannot track 
fast changes present in the true sequence uk and/or a significant delay is introduced. On the other hand, 
undersmoothing may leave the filtered profile hardly usable for making decisions such as whether or 
not an alert should be generated. Figure 4 displays these issues by applying the same MA filter (M = 5, 
with all the ci’s equal to 1) to the signals of Figure 3.  
Figure 4. Same data as in Figure 3: original profile (blue) and outcome (green) of a MA 
filter with M = 5 and = 1. 
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Figure 4. Cont. 
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It is clear that any optimization made on order and weights of MA filtering cannot be directly 
transferred  from  one  sensor  to  another.  For  instance,  CGM  time  series  observed  with  different 
sampling rates must be processed by filters with different parameters (even when they exhibit the same 
SNR, as it happens in some portions of the recordings of Figure 4). Moreover, filter parameters should 
be tuned according to the SNR of the time series, e.g., the higher SNR, the flatter the filtering (and the 
smaller the resulting distortion/delay). How to precisely tune filter parameters in an automatic manner 
is, however, a difficult problem, especially for MA filters. 
Some methods which can be used for denoising CGM signals with approaches more sophisticated 
than MA can be found in several works [33,34,41,42] More recently, the CGM denoising problem has 
been  more  comprehensively  tackled  by  Facchinetti  et  al.  [43],  who  have  proposed  an  approach 
developed within a Bayesian estimation embedding and implemented by Kalman filtering (KF). The 
approach resorts to the idea that an ―optimal‖ filter, i.e., the filter which exhibits the best trade-off 
between noise reduction and signal distortion, can be designed by bringing the filter design problem 
within a Bayesian context [40]. Such an embedding requires the ―a priori‖ second order statistical 
description of signal and noise (―a priori‖ here stands for ―without having seen the measured data‖). In 
detail, vk is described as a white noise with zero mean and unknown variance 
2 (depending on the 
individual  time  series  and,  in  general,  time-varying).  The  unknown  signal  uk  is  modeled  as  the 
realization of a stochastic process obtained by the cascade of a certain number of integrators driven by 
a zero-mean white noise process with (unknown) variance 
2 (these models were already mentioned in 
Section  2).  This  is  a  commonly-used,  simple,  but  versatile  way  to  give  an  a  priori  second  order 
probabilistic description of a smooth time-series. For instance, when a single integrator is considered, 
the random-walk model is used:  
k 1 k k w u u      (7)  
where {wk} is a sequence of white noise samples. Assuming a Gaussian setting, the ―a priori‖ model 
of Equation (7) simply tells us that, given uk-1, then uk will be with probability 99.7% in the range  
uk-1 ±  3, i.e., the lower the  value, the smoother the process {uk}. Here, 
2 is unknown and can be Sensors 2010, 10                                       
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estimated, individually for each time-series, from the data {yk} together with 
2. This is possible using 
CGM data of a burn-in interval, by using a statistically-based smoothing criterion having a maximum 
likelihood interpretation. Once 
2 and 
2 have been estimated, the problem of extracting uk from yk 
(after  the  burn-in  interval)  can  be  numerically  solved,  in  a  computationally  efficient  manner,  by 
resorting to the equations of the causal Kalman filter (KF). Therefore, a key feature of this method is 
that it can individualize the filter parameters 
2 and 
2, and hence the smoothing amount, according to 
the  SNR  of  the  specific  CGM  signal.  Figure  5  shows  an  application  of  this  method  to  the  two 
FreeStyle Navigator® time-series of Figures 1 and 3.  
Figure 5. Application of the Kalman filtering method of Facchinetti et al. [43] to two 
FreeStyle Navigator® time-series exhibiting a different SNR (the green line is the filter 
output). Top panel: same time-series as in the top panel of Figures 3 and 4. Bottom panel: 
same time-series as in the top panel of Figure 1. 
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The variance of the noise component in these two time-series is clearly different. The application of 
the  denoising  procedure  provides  estimates  of  
2  equal,  respectively  from  top  to  bottom,  to  21.4  Sensors 2010, 10                                       
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and 1.8 mg
2/dL
2, in line with the intuition that the first time-series is more noisy than the second one, 
and suggesting that a suitable amount of smoothing is introduced by the filtering method (for sake of 
completeness,  the  correspondent  estimates  of  
2  are  0.14  and  0.06  mg
2/dL
2,  respectively). 
Interestingly, considering the top panel time-series, the time-lag introduced by Kalman filtering in 
Figure 5 is much smaller (1 vs. 2 min) than that obtained, for the same time-series, in Figure 4 (top 
panel) by using MA filtering. 
In Facchinetti et al. [43] the performance of the new KF approach was quantitatively assessed on 
CGM GlucoDay® traces obtained from 24 subjects taken from Maran et al. [44]. Average results 
showed that, for comparable signal denoising, the delay introduced by KF is about 35% less than that 
obtained by MA. In addition, a comprehensive Monte Carlo study on synthetic data showed that the 
method is able to reliably estimate the SNR of the CGM time-series. In Facchinetti et al. [43], it was 
concluded  that  method  is  able  to  deal,  automatically,  with  SNR  inter-sensor  and  inter-individual 
variability. An additional refinement is the possibility of dealing with SNR intra-sensor variability. For 
instance, 
2(and 
2) could be determined continuously on a sliding window [45] in order to track 
possible variations in SNR, e.g., due to possible deterioration of the sensor performance after several 
hours/days. 
4. Prediction 
A natural on-line application of CGM sensors is the prevention of hypo/hyperglycemic events. Only 
a few years after the appearance of CGM sensors in the market, some methods were proposed to 
generate alerts when the actual trend of the glucose concentration profile suggested that hypoglycemia 
was likely to occur within a short time. Such techniques are often termed projection methods. For 
instance, in Choleau et al. [46] an hypo-alert is generated when, on the basis of first-order linear 
extrapolation  of  glucose  obtained  from  the  last  two/three  samples,  there  is  the  risk  that  glucose 
concentration will cross the 70 mg/dL threshold within 20 min. Similar methodologies are conceivably 
implemented in commercial devices in order to timely detect dangerous trends [24]. 
An improvement can be obtained by generating hypo-/hyper-alerts on the basis of ahead-of-time 
prediction  of  glucose  concentration,  which  can  be  computed  from  past  CGM  data  and  suitable  
time-series  models.  The  possibility  of  making  a  short  term  prediction  of  glucose  concentration 
exploiting  its  past  history  was  originally  suggested  in  Bremer  and  Gough  [47],  on  the  basis  of 
preliminary results obtained from modeling blood glucose concentration data (not CGM), measured 
every 10 min in blood for up to 40 h, and using a prediction horizon (PH) of 10 min. Since then, 
several approaches have been proposed using CGM sensor data and a larger, and more clinically 
significant, PH. For instance, in Sparacino et al. [48], two simple low-order (time-varying) time-series 
models were tested in order to assess the possibility to predict glucose concentration, at a PH equal  
to 30 or 45 min, from CGM time-series. In particular, the glucose time-series was described, locally, 
by a first-order polynomial:  
ui = ti +    (8)  
or  by  an  auto-regressive  (AR)  model  of  first-order,  corresponding  to  the  following  time-domain 
difference equation:  Sensors 2010, 10                                       
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ui=a ui-1+wi    (9)  
In Equation (9), i = 1, 2, …n denotes the order of glucose samples collected till the n-th sampling 
time tn and {wi} is a random white noise process with zero mean and variance equal to 
2.  Both 
models, Equations (8) and (9), are simple, but their parameters are adaptive, and are re-identified at 
each sampling time in order to track changes in the signal dynamics. Formally, letting  to denote the 
vector of the parameters of the model employed to describe the glucose time-series, at each sampling 
time tn, a new value of  is determined by fitting past glucose data un, un-1, un-2, ... by weighted linear 
least squares. Once  is determined, the model is used to calculate the prediction of glucose level Q 
steps ahead (where Q is such that Q· Ts = PH, where Ts is the sensor sampling period). For instance, in 
the case of Equation (9): 
û n+Q = a
Q un  (10)  
The  necessity of having a time -varying    is  obvious  in  the  model  of  Equation  (8).  For  other 
models, e.g., AR models, the use of a time-invariant , e.g., identified in a burn-in interval, could 
produce inaccurate predictions because of the nonstationarity of CGM time-series. This is particularly 
true in the case of a low-order model (which can capture signal dynamics only in a limited time-
interval), so a time-varying modeling strategy is in order. In determining the model parameters  at a 
given time, all the past data can participate, possibly with different relative weights. A typical choice is 
to employ exponential weighting, i.e., 
k is the weight of the sample taken k instants before the actual 
sampling time, with , taken in the range (0,1), acting as forgetting factor. If a forgetting factor is not 
used (which is equivalent to letting = 1), glucose samples collected tens of hours, if not days, before 
the actual sampling time would influence prediction, with a possible deterioration of the algorithm 
capability to promptly track changes in the signal, in particular those due to perturbations, e.g., meals. 
From an algorithmic point of view, recursive least squares (RLS) implementations are possible in 
order to estimate the unknown model parameters  in a computationally efficient manner. 
Figure 6 shows the original (solid) vs. the predicted (thin line) time-series for a representative  
type 1 diabetic subject. The predicted time-series were obtained using the AR model of order 1 with  
PH = 30 and, respectively from top to bottom, = 0.85 and 0.99. As apparent from the figure, the 
predicted profile is unavoidably affected by error: in particular, it is delayed and much more noisy than 
the original one. 
Assessing how much such a kind of predicted profiles can be useful for the prevention hypo-/hyper-
glycemia events is critical, but crucial. A straightforward index which could be considered, especially 
for comparing  the relative  performance of different models (e.g., polynomial vs. AR for different 
values of or PH) is the mean square prediction error (MSPE), which can be used to measure how 
close the predicted profile is to the original one. However, in a prediction context, MSPE is of limited 
use, e.g., a very unstable prediction profile may exhibit a smaller MSPE than a more regular prediction 
profile  which  could  be  safer  for  alert  generation.  Therefore,  more  specific  indexes  must  be  
considered [48]. Sensors 2010, 10                                       
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Figure  6.  FreeStyle  Navigator®  time-series  in  a  type  1  diabetic  subject  taken  from 
Kovatchev et al. [30]. Original (blue line) vs. predicted (green line) CGM time-series by 
using an AR model of order 1 with PH = 30 and = 0.85 (too small) and  = 0.99 (too large). 
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A useful index is the energy of the second order differences of the predicted profile (ESOD), which 
reflects  the  presence  of  spurious  oscillations  in  the  predicted  profile  (oscillations  are  obviously 
undesirable, since they can facilitate the generation of false hypo-/hyper-alerts). Another index is the 
delay of the predicted profile with respect to the original curve. In fact, the difference between PH and 
this delay represents a measure of the ―gain in time‖ for alert generation obtained thanks to the use of 
predicted,  instead  of  measured,  CGM  time-series.  Notably,  a  delay  of  the  prediction  profile 
comparable to PH (or larger) would make the prediction profile useless in practice. All the above 
indexes are useful in assessing CGM time-series prediction algorithms. Of note is that, they are all 
dependent on the chosen PH and forgetting factor . For instance, as well visible in Figure 6, a larger  
(bottom panel) provides a more stable prediction profile (smaller ESOD), at the cost of loosing the 
ability to promptly track changes in the glucose trend (larger delay and MSPE). Sensors 2010, 10                                       
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Figure 7 (top panel) displays the predicted profile for the same time-series of Figure 6 obtained with  
PH = 30 but with = 0.95, a value which, retrospectively, realized a suitable compromise among the 
above described merit criteria. The role of  is clear, but PH also plays a crucial role in any prediction 
algorithm. Obviously, one would like to have a PH as large as possible. However, an increase of PH 
causes a larger delay, and thus a larger prediction error, and wider oscillations in the predicted profiles 
(larger MSPE and ESOD) which may affect specificity in alert generation due to larger prediction 
errors. For instance, Figure 7 (bottom panel) illustrates the performance of the same algorithm used in 
Figure 7 (top panel), with the same  = 0.95, when the PH is set to 60 min. Therefore, also the 
maximum allowable PH should be a matter of investigation. In general, the maximum allowable PH 
has to reflect both SNR and sampling rate (e.g., the higher SNR and/or the sampling rate, the higher 
the maximum allowable PH). We strongly encourage that the optimization of  and PH be addressed 
simultaneously and within the same framework. 
Figure 7. Same data of Figure 6: Original (blue) vs. predicted (green) profiles. Top panel: 
= 0.95 and PH = 30. Bottom panel: same  as in top panel, but PH = 60. 
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The problem of assessing the performance of a prediction algorithm has been presented by making 
reference to a specific prediction model, but it is completely general. As a matter of fact, how to Sensors 2010, 10                                       
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optimally design a prediction algorithm for CGM data, e.g., model structure, order, prediction horizon, 
forgetting factor, is still an open issue. The work by Zanderigo et al. [49] considered the possibility of 
using Continuous Glucose Error-Grid Analysis (CG-EGA) [30] to compare the relative performance of 
different prediction algorithms and parameters from a clinical point of view. Another possibility is to 
develop new indexes able to simultaneously take into account all the above cited ingredients. 
Another  work  using  a  low-order  linear  time-series  modeling  to  predict  CGM  is  that  of  Eren-
Oruklu et al.  [50]. In this study, AR of order 3 and AR moving average (ARMA) of order (3,1) 
prediction algorithms were developed and the identification of model parameters was performed by 
using a RLS implementation applying a forgetting factor μ. In addition, the RLS has been integrated 
with a change detection method, which decreases μ to a smaller value when a persistent change in 
model parameters is detected. This modification allows to rapidly capture glycaemic disturbances. The 
assessment of prediction performance has been performed by using as indexes the relative absolute 
difference between predicted and original time-series, the sum of squares of glucose prediction error 
and CG–EGA. Results were satisfactory in terms of accuracy, but no estimates of the prediction delays 
were reported. 
In the approaches above, CGM time-series are described by a model with fixed structure, minimum 
complexity, but with time-varying parameters which, at each sampling time, are re-adjusted on the 
basis of the newly collected glucose sample. Since the model has to describe the time-series only 
―locally‖,  its  complexity  can  be  kept  modest,  a  crucial  aspect  for  using  prediction  algorithms  in  
real-time. Reifman et al. [51] employed a different approach, which was usable only in nine iSense 
CGM time-series (1 min sampling), out of 15 measured. This approach exploited a high-order AR 
model (order 10):  
n
10
1 k
k n k n w u a u  

   (11)  
where un is the glucose samples collected at time tn and wn is a random white noise process. The model 
was first fitted, in each subject, in a burn-in interval and then used within the prediction algorithm for 
the rest of the time-series. A price to be paid for this choice lies in the increased model complexity 
which, in turn, requires the use of a rather long burn-in interval (about 2,000 samples, nearly 36 h). 
Moreover, given the high number of AR parameters to be estimated, the time-series model is overly 
sensitive to noise. Indeed, a ―regularization constraint‖ was placed on the AR coefficients in order to 
decrease their sensitivity to the data. In Reifman et al. [51], the possibility of using a time-invariant 
AR ―population‖ model was also suggested, and further developed in a successive study [52], even if 
the  effect  of  the  likely  prediction  distortion  due  to  the  suboptimality  introduced  by  the  use  of  a 
―population‖ model is critical (e.g., greater risk of generating false positives and negatives). The same 
team recently published also a paper where the same prediction modeling machinery is used to assess 
the relative importance and predictive power of different frequency bands of glucose signals [53]. 
Results suggest that, for short term prediction, no benefits are expected from the inclusion in AR 
models of information concerning meals and insulin intakes. 
In Palerm and Bequette [54] a stochastic nonparametric approach was proposed. The approach was 
applied to 13 data sets of CGMS® data (5 min sampling) during a hypoglycemic clamp (4 h data 
observation). The idea of the method is to exploit the available a priori information on the smoothness Sensors 2010, 10                                       
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of CGM signal, formalized through a stochastic model including the multiple integration of a white 
noise process. After having placed the problem in a state-space setting, e.g.: 



 
  
k k k
k k 1 k
v Cx y
w Φx x
  (12)  
where xk is the state space vector at time k, yk is the measurement vector, ʦ and C are transition 
matrices, and vk and wk are state and measurement noise vectors, the Kalman methodology is used to 
predict  glucose  level after a given  PH. Three different  PH values were tested, i.e., PH = 10, 20,  
and 30 min. The parameters of the Kalman filter were empirically determined, retrospectively, in order 
to ―maximize‖ sensitivity and specificity. The authors reported that the prediction performance, in this 
well-controlled hypoglycaemic clamp situation, was satisfactory in terms of sensitivity and specificity, 
but, again, no estimates of the delays were reported. 
Recently, an artificial neural network model (NNM) has also been applied in the prediction of 
glucose concentrations using CGM data. The use of NNM for glucose prediction is appealing because it 
could  facilitate  the  exploitation  of  information  on  meals  and  insulin  administrations.  In  
Pappada et al. [55] a NNM was developed and trained both with data from the CGMS® and other 
information  manually  recorded  by  the  patient  in  an  electronic  diary  (i.e.,  SMBG  values,  insulin 
dosages, carbohydrate intakes, hypo-/hyper-glycemic symptoms, lifestyle activities). Even if the trend 
prediction is acceptable, the NNM underestimates extreme hyperglycemic values and overestimates 
hypoglycemic values, making the method likely of limited use in real-time applications. Finally, in a 
recent work of Pé rez-Gandí a et al. [56], a real-time prediction algorithm based on NNM, where the 
model was trained by using only CGM data as inputs, was developed. A preliminary assessment of the 
method on six Freestyle Navigator® and on nine CGMS® time-series provided encouraging results.  
5. Alert generation 
A critical problem is the generation of alerts, see Heise et al. [57] for requirements and concepts. 
Real-time alert systems were available e.g., on the Glucowatch® G2 BiograPHer (Cygnus, Redwood 
City, CA, USA), (no longer available in the market) [58] and on the Guardian® (Medtronic Minimed, 
Northridge, CA, USA) [59]. Both systems generate alerts on the basis of the comparison of the actual 
glucose  level  and  a  pre-selected  threshold.  However,  the  efficacy  of  these  systems  is  
controversial [60]. In particular, some studies evidenced the unacceptably high percentage of false 
alerts, which, for allowing sufficient sensitivity, often results higher than 50% [20,61]. In addition, 
these systems cannot avoid the event, because they generate the alert when the event occurs. In order 
to overcome this limitation, some devices now perform a trend analysis, indicating direction and rate 
of change of glucose, in order to provide the patient with an early warning. However, to the best of our 
knowledge, no large scale studies have quantitatively documented in peer-reviewed articles the benefit 
of this procedure.  Sensors 2010, 10                                       
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Figure 8. Risk of generating a false hypo-alert from the original CGM profile (blue line) at 
time 19.2 mitigated by employing an on-line filtered profile (green line) together with its 
confidence interval (shaded area). 
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Generating alerts accurately is difficult, because CGM data are often inaccurate (i.e., biased) due to 
calibration problems and always uncertain (i.e., noisy). The statistical basis behind the generation of 
alerts should thus be put on more solid grounds by considering, in addition to a trivial threshold 
comparison, the uncertainty of the data, which should be estimated in real-time in a statistical setting 
to determine, in real-time, the actual, possibly time-varying, SNR. To better illustrate this issue, in 
Figure 8 we illustrate a CGM profile (blue line) and its filtered version (green line) obtained in real 
time by the method of Facchinetti et al. [43]. Thanks to its Bayesian setting, this method also provides 
the confidence interval (shaded area) of the filtered CGM profile. Remarkably, the higher the noise 
affecting a given portion of data, the larger the confidence interval of the denoised profile. Notably, if 
the original CGM profile (blue line) is used to generate alerts by comparing the actual glucose level 
with a threshold (dashed black horizontal line), there is a significant risk of generating false alerts (see 
e.g., the event at time 19.2). The risk can be mitigated if the filtered profile is considered in the 
decision  criterion,  together  with  the  portion  of  the  confidence  interval  which  exceeds  the  
threshold [45]. Other possibilities can resort to prediction methods, but, at the present time, no results 
are available. However, generating alerts from the prediction is even more difficult than from the 
actual CGM data, given the fact that the ahead-of-time predicted profile is less stable than the original 
one  (see  Figures  6  and  7).  This  exacerbates  the  problem  of  avoiding  false  alerts.  Rendering  the 
predicted profile less sensitive to noise, e.g., by reducing the PH or by increasing the forgetting factor, 
obviously affects sensitivity and reduces the ―temporal gain‖ of prediction and, thus, the practical 
advantage of using the predicted in place of the original CGM profile. Needless to say, strategies to 
generate alerts should take into account not only the nominal predicted glucose level, but also its 
uncertainty. Of note is that the higher the  PH, the larger the confidence interval of the predicted 
glucose level.  
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6. Conclusions 
CGM  sensors  allow  the  development  of  new  strategies  for  the  treatment  of  diabetes.  In  this 
contribution,  we  have  considered  four  specific  issues  which  are  crucial  for  a  ―smart‖  real-time 
application of CGM sensors, in both open-loop (alert generators) and closed-loop (artificial pancreas) 
systems: (re)calibration for enhancing the accuracy of CGM signals, filtering for the enhancement of 
the SNR, ahead-of-time prediction, and generation of hypo/hyper-alerts. The main achievements of the 
literature, and also some open issues, have been discussed.  
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